Strides Shasun prices QIP at a discount
Indian pharmaceutical company Strides Shasun Arcolabs has priced a qualified institutional placement — which raised Rp11.03bn ($166.4m) — below its floor price, according to a filing with India’s National Stock Exchange on Monday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: